CLINICAL IMPACT OF PREEXISTING AND DE NOVO ANTI-ENDOTHELIAL CELL ANTIBODIES DETECTED BY A NEW INDIRECT IMMUNOFLUORESCENCE ASSAY IN KIDNEY AND PANCREAS TRANSPLANTATION